{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:03:47Z","timestamp":1793577827436,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Huntington\u2019s disease (HD) is a rare dominantly inheritable autosomal neurodegenerative disease with unclear pathophysiological pathways. In neurodegenerative disorders, including HD, necroptosis plays a significant role in neuronal death. Morin hydrate (MH), a natural bioactive flavonoid, has various pharmacological properties via orchestrating neuroinflammation, apoptosis, and necroptosis. Up to now, there is no extant data on the impact of MH on the necroptotic pathway in HD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>This research aimed to scrutinize the effect of MH on neurodegeneration initiated by 3-nitropropionic acid (3-NP) administration in rats via modulating necroptosis and apoptosis signaling pathways and compare it with necrosulfonamide (NSA) as a necroptosis inhibitor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HD was triggered in male wistar rats by intraperitoneal injection of 3-NP (10\u00a0mg\/kg\/day) for 14 days. Intraperitoneal injection of MH (20\u00a0mg\/kg\/day, i.p.) or NSA (1.65\u00a0mg\/kg\/day, i.p.) an hour prior to 3-NP administration for 14 days. At the end of study, rats were weighed, and their locomotor activity was assessed via grip strength and open field tests. Striata of rats were investigated histologically and immunohistochemically by evaluation the expression levels of glial fibrillary acidic protein (GFAP). Striatal tumor necrosis factor-alpha (TNF-\u03b1), caspase 3, and 8 levels were quantified through the ELISA technique, while striatal expression of necroptosis-associated proteins; phosphorylated form of receptor interacting protein kinase 1\/3(p-RIPK1, p-RIPK3) and phosphorylated form of mixed lineage kinase domain-like protein (p-MLKL) were assessed by the Western blot technique. Striatal succinate dehydrogenase (SDH) activity was assayed colorimetrically. Finally, gene enrichment analysis using ShinyGO was employed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>MH and NSA significantly mitigated body weight loss and ameliorated locomotor deterioration, besides reversing histological abnormalities in the striatum of rats. Intriguingly, MH exerted similar effects on specific biomarkers and molecular signals as NSA. MH and NSA inhibited neuroinflammation, apoptosis, and necroptosis by significantly decreasing the striatal (TNF-\u03b1), caspase 3, and necroptosis-associated proteins (P-RIPK1, P-RIPK3, and P-MLKL) levels. Besides, MH and NSA also decreased striatal GFAP and increased SDH activity. Gene enrichment analysis revealed a significant interaction between genes. Together, MH exerts a neuroprotective action on 3-NP-elicited HD rats via reducing neuroinflammation, apoptosis, and necroptosis. This study highlights MH as a potential protection against HD, calling for further research to confirm its neuroprotective effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01172-y","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:26:01Z","timestamp":1744363561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neuroprotective role of morin hydrate on 3-nitropropionic acid-elicited huntington's disease: in vivo investigation of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Eman M.","family":"Elbaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab H.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Abdelkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef Tadros","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"1172_CR1","doi-asserted-by":"publisher","unstructured":"Abd El-Aal SA, El-Abhar HS, Abulfadl YS. Morin offsets PTZ-induced neuronal degeneration and cognitive decrements in rats: The modulation of TNF-\u03b1\/TNFR-1\/RIPK1,3\/MLKL\/PGAM5\/Drp-1, IL-6\/JAK2\/STAT3\/GFAP and Keap-1\/Nrf-2\/HO-1 trajectories. Eur J Pharmacol. 2022;931. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175213.","DOI":"10.1016\/j.ejphar.2022.175213"},{"key":"1172_CR2","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10787-023-01269-y","volume":"31","author":"R Abdelhady","year":"2023","unstructured":"Abdelhady R, Younis NS, Ali O, Shehata S, Sayed RH, Nadeem RI. Cognitive enhancing effects of pazopanib in D\u2013galactose\/ovariectomized Alzheimer\u2019s rat model: insights into the role of RIPK1\/RIPK3\/MLKL necroptosis signaling pathway. Inflammopharmacology. 2023;31:2719\u201329. https:\/\/doi.org\/10.1007\/s10787-023-01269-y.","journal-title":"Inflammopharmacology"},{"key":"1172_CR3","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s12035-015-9303-2","volume":"53","author":"LA Ahmed","year":"2016","unstructured":"Ahmed LA, Darwish HA, Abdelsalam RM, Amin HAA. Role of Rho kinase Inhibition in the protective effect of fasudil and Simvastatin against 3-Nitropropionic Acid-Induced striatal neurodegeneration and mitochondrial dysfunction in rats. Mol Neurobiol. 2016;53:3927\u201338. https:\/\/doi.org\/10.1007\/s12035-015-9303-2.","journal-title":"Mol Neurobiol"},{"key":"1172_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1179\/1351000211Y.0000000019","volume":"17","author":"KS Al Numair","year":"2012","unstructured":"Al Numair KS, Chandramohan G, Alsaif MA, Baskar AA. Protective effect of Morin on cardiac mitochondrial function during isoproterenolinduced myocardial infarction in male Wistar rats. Redox Rep. 2012;17:14\u201321. https:\/\/doi.org\/10.1179\/1351000211Y.0000000019.","journal-title":"Redox Rep"},{"key":"1172_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcb.20748","volume":"98","author":"S Almeida","year":"2006","unstructured":"Almeida S, Brett AC, G\u00f3is IN, Oliveira CR, Rego AC. Caspase-dependent and -independent cell death induced by 3-nitropropionic acid in rat cortical neurons. J Cell Biochem. 2006;98:93\u2013101. https:\/\/doi.org\/10.1002\/jcb.20748.","journal-title":"J Cell Biochem"},{"key":"1172_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/0300985821999831","volume":"58","author":"G Avallone","year":"2021","unstructured":"Avallone G, Rasotto R, Chambers JK, Miller AD, Behling-Kelly E, Monti P, Berlato D, Valenti P, Roccabianca P. Review of histological grading systems in veterinary medicine. Vet Pathol. 2021;58:809\u201328. https:\/\/doi.org\/10.1177\/0300985821999831.","journal-title":"Vet Pathol"},{"key":"1172_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/biof.1397","volume":"44","author":"P Bachewal","year":"2018","unstructured":"Bachewal P, Gundu C, Yerra VG, Kalvala AK, Areti A, Kumar A. Morin exerts neuroprotection via Attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. BioFactors. 2018;44:109\u201322. https:\/\/doi.org\/10.1002\/biof.1397.","journal-title":"BioFactors"},{"key":"1172_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2011.112","volume":"2","author":"D Bano","year":"2011","unstructured":"Bano D, Zanetti F, Mende Y, Nicotera P. Neurodegenerative processes in Huntington\u2019s disease. Cell Death Dis. 2011;2:1\u20137. https:\/\/doi.org\/10.1038\/cddis.2011.112.","journal-title":"Cell Death Dis"},{"key":"1172_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Berghe","year":"2014","unstructured":"Berghe T, Vanden, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15:135\u201347. https:\/\/doi.org\/10.1038\/nrm3737.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1172_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99\u2013109. https:\/\/doi.org\/10.1038\/nrmicro2070.","journal-title":"Nat Rev Microbiol"},{"key":"1172_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, Khalili-Shirazi A, Lowdell MW, Brundin P, Bates GP, Leavitt BR, M\u00f6ller T, Tabrizi SJ. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med. 2008;205:1869\u201377. https:\/\/doi.org\/10.1084\/jem.20080178.","journal-title":"J Exp Med"},{"key":"1172_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0149-7634(96)00027-9","volume":"21","author":"CV Borlongan","year":"1997","unstructured":"Borlongan CV, Koutouzis TK, Sanberg PR. 3-Nitropropionic acid animal model and Huntington\u2019s disease. Neurosci Biobehav Rev. 1997;21:289\u201393. https:\/\/doi.org\/10.1016\/S0149-7634(96)00027-9.","journal-title":"Neurosci Biobehav Rev"},{"key":"1172_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3.","journal-title":"Anal Biochem"},{"key":"1172_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuro.2019.11.004","volume":"76","author":"H \u00c7elik","year":"2020","unstructured":"\u00c7elik H, Kucukler S, \u00c7omakl\u0131 S, \u00d6zdemir S, Caglayan C, Yard\u0131m A, Kandemir FM. Morin attenuates ifosfamide-induced neurotoxicity in rats via suppression of oxidative stress, neuroinflammation and neuronal apoptosis. Neurotoxicology. 2020;76:126\u201337. https:\/\/doi.org\/10.1016\/j.neuro.2019.11.004.","journal-title":"Neurotoxicology"},{"key":"1172_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.21010\/ajtcam.v14i2.36","volume":"14","author":"Y Chen","year":"2017","unstructured":"Chen Y, Li Y, Xu H, Li G, Ma Y, Pang YJ. Morin mitigates oxidative stress, apoptosis and inflammation in cerebral ischemic rats. Afr J Tradit Complement Altern Med AJTCAM. 2017;14:348\u201355. https:\/\/doi.org\/10.21010\/ajtcam.v14i2.36.","journal-title":"Afr J Tradit Complement Altern Med AJTCAM"},{"key":"1172_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuint.2009.10.006","volume":"56","author":"C Cleren","year":"2010","unstructured":"Cleren C, Calingasan NY, Starkov A, Jacquard C, Chen J, Brouillet E, Beal MF. Promethazine protects against 3-nitropropionic acid-induced neurotoxicity. Neurochem Int. 2010;56:208\u201312. https:\/\/doi.org\/10.1016\/j.neuint.2009.10.006.","journal-title":"Neurochem Int"},{"key":"1172_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019 IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, Yuan J. Identification of RIP1 kinase as a specific cellular target of Necrostatins. Nat Chem Biol. 2008;4:313\u201321. https:\/\/doi.org\/10.1038\/nchembio.83.","journal-title":"Nat Chem Biol"},{"key":"1172_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1235-0","volume":"15","author":"YK Dhuriya","year":"2018","unstructured":"Dhuriya YK, Sharma D. Necroptosis: A regulated inflammatory mode of cell death. J Neuroinflammation. 2018;15:1\u20139. https:\/\/doi.org\/10.1186\/s12974-018-1235-0.","journal-title":"J Neuroinflammation"},{"key":"1172_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0203837","volume":"13","author":"H El-Abhar","year":"2018","unstructured":"El-Abhar H, Abd El Fattah MA, Wadie W, El-Tanbouly DM. Cilostazol disrupts TLR-4, Akt\/GSK-3\u03b2\/CREB, and IL-6\/JAK-2\/STAT-3\/SOCS-3 crosstalk in a rat model of Huntington\u2019s disease. PLoS ONE. 2018;13:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0203837.","journal-title":"PLoS ONE"},{"key":"1172_CR20","doi-asserted-by":"publisher","first-page":"122362","DOI":"10.1016\/j.lfs.2023.122362","volume":"338","author":"MA El-Emam","year":"2024","unstructured":"El-Emam MA, Sheta E, El-Abhar HS, Abdallah DM, El Kerdawy AM, Eldehna WM, Gowayed MA. Morin suppresses mTORc1\/IRE-1\u03b1\/JNK and IP3R-VDAC-1 pathways: crucial mechanisms in apoptosis and mitophagy Inhibition in experimental Huntington\u2019s disease, supported by in Silico molecular Docking simulations. Life Sci. 2024;338:122362. https:\/\/doi.org\/10.1016\/j.lfs.2023.122362.","journal-title":"Life Sci"},{"key":"1172_CR21","doi-asserted-by":"publisher","first-page":"104548","DOI":"10.1016\/j.neuint.2019.104548","volume":"131","author":"EM Elbaz","year":"2019","unstructured":"Elbaz EM, Helmy HS, El-Sahar AE, Saad MA, Sayed RH. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington\u2019s disease model rats via modulation of the calcium\/calcineurin\/NFATc4 and Wnt\/\u03b2-catenin signalling pathways. Neurochem Int. 2019;131:104548. https:\/\/doi.org\/10.1016\/j.neuint.2019.104548.","journal-title":"Neurochem Int"},{"key":"1172_CR22","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1039\/d2fo00645f","volume":"13","author":"MI Ezzat","year":"2022","unstructured":"Ezzat MI, Issa MY, Sallam IE, Zaafar D, Khalil HMA, Mousa MR, Sabry D, Gawish AY, Elghandour AH, Mohsen E. Impact of different processing methods on the phenolics and neuroprotective activity of Fragaria Ananassa Duch. Extracts in a d-galactose and aluminum chloride-induced rat model of aging. Food Funct. 2022;13:7794\u2013812. https:\/\/doi.org\/10.1039\/d2fo00645f.","journal-title":"Food Funct"},{"issue":"6","key":"1172_CR23","doi-asserted-by":"publisher","first-page":"a007476","DOI":"10.1101\/cshperspect.a007476","volume":"3","author":"S Finkbeiner","year":"2011","unstructured":"Finkbeiner S. Huntington\u2019s disease. Cold Spring Harb Perspect Biol. 2011;3(6):a007476.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1172_CR24","doi-asserted-by":"crossref","unstructured":"Flaisher-Grinberg S, Einat H. (2009) Mice models for the manic pole of bipolar disorder.","DOI":"10.1007\/978-1-60761-303-9_16"},{"key":"1172_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1056\/nejmra022366","volume":"348","author":"RM Friedlander","year":"2003","unstructured":"Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365\u201375. https:\/\/doi.org\/10.1056\/nejmra022366.","journal-title":"N Engl J Med"},{"key":"1172_CR26","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Jung D, Yao R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"key":"1172_CR27","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","volume":"29","author":"RK Graham","year":"2009","unstructured":"Graham RK, Pouladi MA, Joshi P, Lu G, Deng Y, Wu NP, Figueroa BE, Metzler M, Andr\u00e9 VM, Slow EJ, Raymond L, Friedlander R, Levine MS, Leavitt BR, Hayden MR. Differential susceptibility to excitotoxic stress in YAC128 mouse models of huntington disease between initiation and progression of disease. J Neurosci. 2009;29:2193\u2013204. https:\/\/doi.org\/10.1523\/JNEUROSCI.5473-08.2009.","journal-title":"J Neurosci"},{"key":"1172_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10495-009-0334-x","volume":"14","author":"W Han","year":"2009","unstructured":"Han W, Xie J, Li L, Liu Z, Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis. 2009;14:674\u201386. https:\/\/doi.org\/10.1007\/s10495-009-0334-x.","journal-title":"Apoptosis"},{"key":"1172_CR29","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1046\/j.1523-1755.1998.00202.x","volume":"54","author":"E Healy","year":"1998","unstructured":"Healy E, Dempsey M, Lally C, Ryan MP. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int. 1998;54:1955\u201366. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00202.x.","journal-title":"Kidney Int"},{"key":"1172_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","volume":"27","author":"MA Hickey","year":"2003","unstructured":"Hickey MA, Chesselet MF. Apoptosis in Huntington\u2019s disease. Prog Neuro-Psychopharmacology Biol Psychiatry. 2003;27:255\u201365. https:\/\/doi.org\/10.1016\/S0278-5846(03)00021-6.","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"1172_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.043.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1172_CR47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J. Fas triggers an alternative, caspase-8\u2013independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1(6):489\u201395.","journal-title":"Nat Immunol"},{"key":"1172_CR32","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","volume":"23","author":"HY Hsiao","year":"2014","unstructured":"Hsiao HY, Chiu FL, Chen CM, Wu YR, Chen HM, Chen YC, Kuo HC, Chern Y. Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease. Hum Mol Genet. 2014;23:4328\u201344. https:\/\/doi.org\/10.1093\/hmg\/ddu151.","journal-title":"Hum Mol Genet"},{"key":"1172_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1440-1630.1999.00182.x","volume":"46","author":"E Innes","year":"1999","unstructured":"Innes E. Handgrip strength testing: A review of the literature. Aust Occup Ther J. 1999;46:120\u201340. https:\/\/doi.org\/10.1046\/j.1440-1630.1999.00182.x.","journal-title":"Aust Occup Ther J"},{"key":"1172_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01538","volume":"10","author":"J Jiao","year":"2019","unstructured":"Jiao J, Wang Y, Ren P, Sun S, Wu M. Necrosulfonamide ameliorates neurological impairment in spinal cord injury by improving antioxidative capacity. Front Pharmacol. 2019;10:1\u201313. https:\/\/doi.org\/10.3389\/fphar.2019.01538.","journal-title":"Front Pharmacol"},{"key":"1172_CR35","doi-asserted-by":"publisher","first-page":"19367","DOI":"10.18632\/oncotarget.8346","volume":"7","author":"H Jie","year":"2016","unstructured":"Jie H, He Y, Huang X, Zhou Q, Han Y, Li X, Bai Y, Sun E. Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis. Oncotarget. 2016;7:19367\u201381. https:\/\/doi.org\/10.18632\/oncotarget.8346.","journal-title":"Oncotarget"},{"key":"1172_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1006\/exnr.2001.7755","volume":"171","author":"CD Keene","year":"2001","unstructured":"Keene CD, Rodrigues CMP, Eich T, Linehan-Stieers C, Abt A, Kren BT, Steer CJ, Low WC. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington\u2019s disease. Exp Neurol. 2001;171:351\u201360. https:\/\/doi.org\/10.1006\/exnr.2001.7755.","journal-title":"Exp Neurol"},{"key":"1172_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2013.238","volume":"4","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Li J. Caspase Blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia. Cell Death Dis. 2013;4:1\u201312. https:\/\/doi.org\/10.1038\/cddis.2013.238.","journal-title":"Cell Death Dis"},{"key":"1172_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopha.2018.06.161","volume":"106","author":"M Kuzu","year":"2018","unstructured":"Kuzu M, Kandemir FM, Yildirim S, Kucukler S, Caglayan C, Turk E. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmacother. 2018;106:443\u201353. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.161.","journal-title":"Biomed Pharmacother"},{"key":"1172_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1471-4159.2009.06331.x","volume":"111","author":"R Lagoa","year":"2009","unstructured":"Lagoa R, Lopez-Sanchez C, Samhan-Arias AK, Ga\u00f1an CM, Garcia-Martinez V, Gutierrez-Merino C. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. J Neurochem. 2009;111:473\u201387. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06331.x.","journal-title":"J Neurochem"},{"key":"1172_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/nejmra1310050","volume":"370","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Green DR. Necroptosis. N Engl J Med. 2014;370:455\u201365. https:\/\/doi.org\/10.1056\/nejmra1310050.","journal-title":"N Engl J Med"},{"key":"1172_CR41","doi-asserted-by":"publisher","unstructured":"Ma Y, Ge A, Zhu W, Liu YN, Ji NF, Zha WJ, Zhang JX, Zeng XN, Huang M. (2016) Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling. Oxid Med Cell Longev 2016. https:\/\/doi.org\/10.1155\/2016\/5843672","DOI":"10.1155\/2016\/5843672"},{"key":"1172_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cbi.2018.10.030","volume":"298","author":"G Menacher","year":"2019","unstructured":"Menacher G, Balszuweit F, Lang S, Thiermann H, Kehe K, Gudermann T, Schmidt A, Steinritz D, Popp T. Necrosulfonamide\u2013 Unexpected effect in the course of a sulfur mustard intoxication. Chem Biol Interact. 2019;298:80\u20135. https:\/\/doi.org\/10.1016\/j.cbi.2018.10.030.","journal-title":"Chem Biol Interact"},{"key":"1172_CR43","doi-asserted-by":"publisher","first-page":"147444","DOI":"10.1016\/j.brainres.2021.147444","volume":"1762","author":"MH Moghaddam","year":"2021","unstructured":"Moghaddam MH, Bayat AH, Eskandari N, Abdollahifar M, amin, Fotouhi F, Forouzannia A, Rafiei R, Hatari S, Seraj A, Shahidi AMEJ, Ghorbani Z, Peyvandi AA, Aliaghaei A. Elderberry diet ameliorates motor function and prevents oxidative stress-induced cell death in rat models of huntington disease. Brain Res. 2021;1762:147444. https:\/\/doi.org\/10.1016\/j.brainres.2021.147444.","journal-title":"Brain Res"},{"key":"1172_CR44","doi-asserted-by":"publisher","first-page":"109771","DOI":"10.1016\/j.intimp.2023.109771","volume":"116","author":"OE Mohamed","year":"2023","unstructured":"Mohamed OE, Abdallah DM, Fayez AM, Mohamed RA, El-Abhar HS. Morin post-treatment surpassed Calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate\/calpain axis, Kidins220, and BDNF\/TrkB\/AKT\/CREB trajectory. Int Immunopharmacol. 2023;116:109771. https:\/\/doi.org\/10.1016\/j.intimp.2023.109771.","journal-title":"Int Immunopharmacol"},{"key":"1172_CR45","doi-asserted-by":"publisher","first-page":"174506","DOI":"10.1016\/j.ejphar.2021.174506","volume":"910","author":"N Mohammadi","year":"2021","unstructured":"Mohammadi N, Asle-Rousta M, Rahnema M, Amini R. Morin attenuates memory deficits in a rat model of Alzheimer\u2019s disease by ameliorating oxidative stress and neuroinflammation. Eur J Pharmacol. 2021;910:174506. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174506.","journal-title":"Eur J Pharmacol"},{"key":"1172_CR46","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acschemneuro.0c00516","volume":"11","author":"TMK Motawi","year":"2020","unstructured":"Motawi TMK, Abdel-Nasser ZM, Shahin NN. Ameliorative effect of necrosulfonamide in a rat model of Alzheimer\u2019s disease: targeting mixed lineage kinase Domain-like Protein-Mediated necroptosis. ACS Chem Neurosci. 2020;11:3386\u201397. https:\/\/doi.org\/10.1021\/acschemneuro.0c00516.","journal-title":"ACS Chem Neurosci"},{"key":"1172_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0197-0186(02)00229-2","volume":"43","author":"P Nasr","year":"2003","unstructured":"Nasr P, Gursahani HI, Pang Z, Bondada V, Lee J, Hadley RW, Geddes JW. Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and Calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochem Int. 2003;43:89\u201399. https:\/\/doi.org\/10.1016\/S0197-0186(02)00229-2.","journal-title":"Neurochem Int"},{"key":"1172_CR49","first-page":"34","volume":"5","author":"MJU Novak","year":"2010","unstructured":"Novak MJU, Tabrizi SJ. Clinical review Huntington\u2019s disease. Br Med J. 2010;5:34\u201340.","journal-title":"Br Med J"},{"key":"1172_CR50","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.celrep.2015.02.051","volume":"10","author":"D Ofengeim","year":"2015","unstructured":"Ofengeim D, Ito Y, Najafov A, Zhang Y, Shan B, DeWitt JP, Ye J, Zhang X, Chang A, Vakifahmetoglu-Norberg H, Geng J, Py B, Zhou W, Amin P, Lima JB, Qi C, Yu Q, Trapp B, Yuan J. Activation of necroptosis in multiple sclerosis. Cell Rep. 2015;10:1836\u201349. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.051.","journal-title":"Cell Rep"},{"key":"1172_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41419-018-0872-7","volume":"9","author":"SR Oliveira","year":"2018","unstructured":"Oliveira SR, Amaral JD, Rodrigues CMP. Mechanism and disease implications of necroptosis and neuronal inflammation. Cell Death Dis. 2018;9:10\u20132. https:\/\/doi.org\/10.1038\/s41419-018-0872-7.","journal-title":"Cell Death Dis"},{"key":"1172_CR52","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41418-019-0408-4","volume":"27","author":"M O\u00f1ate","year":"2020","unstructured":"O\u00f1ate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I, Gamez N, Soto P, Soto C, Hetz C, Court FA. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death Differ. 2020;27:1169\u201385. https:\/\/doi.org\/10.1038\/s41418-019-0408-4.","journal-title":"Cell Death Differ"},{"key":"1172_CR53","doi-asserted-by":"publisher","unstructured":"Onk D, Onk OA, Turkmen K, Erol HS, Ayazoglu TA, Keles ON, Halici M, Topal E. (2016) Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress. Mediators Inflamm 2016. https:\/\/doi.org\/10.1155\/2016\/9050828","DOI":"10.1155\/2016\/9050828"},{"key":"1172_CR54","doi-asserted-by":"publisher","unstructured":"Park MY, Ha SE, Vetrivel P, Kim HH, Bhosale PB, Abusaliya A, Kim GS. (2021) Differences of Key Proteins between Apoptosis and Necroptosis. Biomed Res Int 2021. https:\/\/doi.org\/10.1155\/2021\/3420168","DOI":"10.1155\/2021\/3420168"},{"key":"1172_CR55","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-006-0198-8","volume":"253","author":"LR Pattison","year":"2006","unstructured":"Pattison LR, Kotter MR, Fraga D, Bonelli RM. Apoptotic cascades as possible targets for inhibiting cell death in Huntington\u2019s disease. J Neurol. 2006;253:1137\u201342. https:\/\/doi.org\/10.1007\/s00415-006-0198-8.","journal-title":"J Neurol"},{"key":"1172_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-43627-3","volume":"9","author":"J Pido-Lopez","year":"2019","unstructured":"Pido-Lopez J, Tanudjojo B, Farag S, Bondulich MK, Andre R, Tabrizi SJ, Bates GP. Inhibition of tumour necrosis factor alpha in the R6\/2 mouse model of Huntington\u2019s disease by etanercept treatment. Sci Rep. 2019;9:1\u201312. https:\/\/doi.org\/10.1038\/s41598-019-43627-3.","journal-title":"Sci Rep"},{"key":"1172_CR58","doi-asserted-by":"publisher","first-page":"111511","DOI":"10.1016\/j.biopha.2021.111511","volume":"138","author":"SA Rajput","year":"2021","unstructured":"Rajput SA, Wang X, qi, Yan HC. Morin hydrate: A comprehensive review on novel natural dietary bioactive compound with versatile biological and Pharmacological potential. Biomed Pharmacother. 2021;138:111511. https:\/\/doi.org\/10.1016\/j.biopha.2021.111511.","journal-title":"Biomed Pharmacother"},{"key":"1172_CR57","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2174\/1389450111007011218","volume":"11","author":"R Rosenstock","year":"2012","unstructured":"Rosenstock R, Duarte TI, Cristina Rego A A. Mitochondrial-Associated metabolic changes and neurodegeneration in huntingtons Disease - from clinical features to the bench. Curr Drug Targets. 2012;11:1218\u201336. https:\/\/doi.org\/10.2174\/1389450111007011218.","journal-title":"Curr Drug Targets"},{"key":"1172_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/biof.1013","volume":"38","author":"MA Sorolla","year":"2012","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Vall-llaura N, Tamarit J, Ros J, Cabiscol E. Protein oxidation in huntington disease. BioFactors. 2012;38:173\u201385. https:\/\/doi.org\/10.1002\/biof.1013.","journal-title":"BioFactors"},{"key":"1172_CR60","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, La Cruz VP, De, Santamar\u00eda A. 3-nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules. 2010;15:878\u2013916. https:\/\/doi.org\/10.3390\/molecules15020878.","journal-title":"Molecules"},{"key":"1172_CR61","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.jtcvs.2021.01.037","volume":"163","author":"S Ueda","year":"2022","unstructured":"Ueda S, Chen-Yoshikawa TF, Tanaka S, Yamada Y, Nakajima D, Ohsumi A, Date H. Protective effect of necrosulfonamide on rat pulmonary ischemia-reperfusion injury via Inhibition of necroptosis. J Thorac Cardiovasc Surg. 2022;163:e113\u201322. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.01.037.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9557","key":"1172_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369(9557):218\u201328.","journal-title":"Lancet"},{"key":"1172_CR63","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4103\/1673-5374.160108","volume":"10","author":"JR Wu","year":"2015","unstructured":"Wu JR, Wang J, Zhou SK, Yang L, Yin J, Le, Cao JP, Cheng YB. Necrostatin-1 protection of dopaminergic neurons. Neural Regen Res. 2015;10:1120\u20134. https:\/\/doi.org\/10.4103\/1673-5374.160108.","journal-title":"Neural Regen Res"},{"key":"1172_CR64","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.apsb.2020.01.007","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu Y, Dong G, Sheng C. Targeting necroptosis in anticancer therapy: mechanisms and modulators. Acta Pharm Sin B. 2020;10:1601\u201318. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.007.","journal-title":"Acta Pharm Sin B"},{"key":"1172_CR65","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2003.11.023","volume":"36","author":"KA Youdim","year":"2004","unstructured":"Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 2004;36:592\u2013604. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2003.11.023.","journal-title":"Free Radic Biol Med"},{"key":"1172_CR70","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/aps.2010.77","volume":"31","author":"ZT Zhang","year":"2010","unstructured":"Zhang ZT, Cao XB, Xiong N, Wang HC, Huang JS, Sun SG, Wang T. Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo. Acta Pharmacol Sin. 2010;31:900\u20136. https:\/\/doi.org\/10.1038\/aps.2010.77.","journal-title":"Acta Pharmacol Sin"},{"key":"1172_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2017.286","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S, Tang MB, Luo HY, Shi CH, Xu YM. Necroptosis in neurodegenerative diseases: A potential therapeutic target. Cell Death Dis. 2017;8:1\u20139. https:\/\/doi.org\/10.1038\/cddis.2017.286.","journal-title":"Cell Death Dis"},{"key":"1172_CR69","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00210-019-01656-9","volume":"392","author":"YY Zhang","year":"2019","unstructured":"Zhang YY, Liu WN, Li YQ, Zhang XJ, Yang J, Luo XJ, Peng J. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1\/RIPK3\/MLKL pathway. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:1085\u201395. https:\/\/doi.org\/10.1007\/s00210-019-01656-9.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1172_CR66","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.26355\/eurrev_202003_20538","volume":"24","author":"QX Zhang","year":"2020","unstructured":"Zhang QX, Guo D, Wang FC, Ding WY. Necrosulfonamide (NSA) protects intervertebral disc degeneration via necroptosis and apoptosis Inhibition. Eur Rev Med Pharmacol Sci. 2020;24:2683\u201391. https:\/\/doi.org\/10.26355\/eurrev_202003_20538.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1172_CR68","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhang Y, Wang F, Liu Y, Yong VW, Xue M. Necrosulfonamide alleviates acute brain injury of intracerebral hemorrhage via inhibiting inflammation and necroptosis. Front Mol Neurosci. 2022;15. https:\/\/doi.org\/10.3389\/fnmol.2022.916249.","DOI":"10.3389\/fnmol.2022.916249"},{"key":"1172_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/cddis.2010.94","volume":"2","author":"S Zhu","year":"2011","unstructured":"Zhu S, Zhang Y, Bai G, Li H. Necrostatin-1 ameliorates symptoms in R6\/2 Transgenic mouse model of Huntington\u2019s disease. Cell Death Dis. 2011;2:6\u20139. https:\/\/doi.org\/10.1038\/cddis.2010.94.","journal-title":"Cell Death Dis"},{"key":"1172_CR72","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev. 2010;90:905\u201381. https:\/\/doi.org\/10.1152\/physrev.00041.2009.","journal-title":"Physiol Rev"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01172-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01172-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01172-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:26:08Z","timestamp":1744363568000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01172-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01172-y","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study\u2019s protocols were approved by the Ethics Committee for Animal Experimentation at the Faculty of Pharmacy, Cairo University (Permit Number: PT 3059).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}